Skeletal related events in patients with bone metastasis arising from non-small cell lung cancer

Systematic Literature Review and Network Meta-Analysis Comparing Bone-Targeted Agents for the Prevention of Skeletal-Related Events in Cancer Patients With Bone Metastasis

(2015) Z. Wang et al.   ONCOLOGIST

Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours

(2014) J Ford et al.   HEALTH TECHNOLOGY ASSESSMENT

Prospective Study on the Incidence of Bone Metastasis (BM) and Skeletal-Related Events (SREs) in Patients (pts) with Stage IIIB and IV Lung Cancer—CSP-HOR 13

(2014) Nobuyuki Katakami et al.   Journal of Thoracic Oncology

Bone metastasis, skeletal-related events, and mortality in lung cancer patients: A Danish population-based cohort study

(2014) Karynsa Cetin et al.   LUNG CANCER

Use of intravenous bisphosphonates in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems

(2014) Gerry Oster et al.   SUPPORTIVE CARE IN CANCER

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems

(2013) Gerry Oster et al.   SUPPORTIVE CARE IN CANCER

Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors

(2013) David Henry et al.   SUPPORTIVE CARE IN CANCER

Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis

(2012) Prashanth Peddi et al.   CANCER TREATMENT REVIEWS

Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials

(2012) Allan Lipton et al.   EUROPEAN JOURNAL OF CANCER

Prognostic factors for non-small cell lung cancer with bone metastasis at the time of diagnosis

(2012) Hyun-Mi Bae et al.   LUNG CANCER

Bisphosphonates in the treatment of patients with lung cancer and metastatic bone disease: a systematic review and meta-analysis

(2012) Maria A. Lopez-Olivo et al.   SUPPORTIVE CARE IN CANCER

Factors Associated With The Development Of Skeletal-related Events In Non-small Cell Lung Cancer Patients With Bone Metastases

(2011) J. Wei et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Annual Report to the Nation on the Status of Cancer, 1975-2007, Featuring Tumors of the Brain and Other Nervous System

(2011) B. A. Kohler et al.   JNCI-Journal of the National Cancer Institute

Epidemiology and Treatment Costs of Bone Metastases from Lung Cancer: A French Prospective, Observational, Multicenter Study (GFPC 0601)

(2011) Chantal Decroisette et al.   Journal of Thoracic Oncology

Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases

(2010) Jong-Mu Sun et al.   LUNG CANCER

Skeletal Disease Contributes Substantially to Morbidity and Mortality in Patients with Lung Cancer

(2009) Vera Hirsh   Clinical Lung Cancer

Bisphosphonate Use in Patients with Lung Cancer and Bone Metastases: Recommendations of a European Expert Panel

(2009) Filippo De Marinis et al.   Journal of Thoracic Oncology

Prevention and Management of Bone Metastases in Lung Cancer: A Review

(2009) Hamed Al Husaini et al.   Journal of Thoracic Oncology

Risk factors for skeletal-related events in patients with non-small cell lung cancer treated by chemotherapy

(2008) Ikuo Sekine et al.   LUNG CANCER